The global cell banking outsourcing market size accounted for USD 14.38 billion in 2024, grew to USD 16.07 billion in 2025 and is expected to be worth around USD 43.59 billion by 2034, registering a solid CAGR of 11.72% between 2024 and 2034. The North America cell banking outsourcing market size is calculated at USD 5.90 billion in 2024 and is estimated to grow at a fastest CAGR of 11.86% during the forecast period.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Cell Banking Outsourcing Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Cell Banking Outsourcing Market, by Type, 2024-2034
8.1.1 Master Cell Banking
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Working Cell Banking
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Viral Cell Banking
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. Cell Banking Outsourcing Market, by Cell Type, 2024-2034
9.1.1. Stem Cell
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Non-Stem Cell
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Cell Banking Outsourcing Market, by Phase, 2024-2034
10.1.1. Bank Storage
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Bank Characterization & Testing
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Bank Preparation
10.1.3.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.1.3. Market Revenue and Forecast, by Phase (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Phase (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Phase (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.2.3. Market Revenue and Forecast, by Phase (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Phase (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Phase (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Phase (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Phase (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.3.3. Market Revenue and Forecast, by Phase (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Phase (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Phase (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Phase (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Phase (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.4.3. Market Revenue and Forecast, by Phase (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Phase (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Phase (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Phase (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Type (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Phase (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.5.3. Market Revenue and Forecast, by Phase (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Phase (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Type (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Cell Type (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Phase (2021-2034)
12.1. Bio Outsource (Sartorious)
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BSL Bioservice
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Cryo-Cell International, Inc
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Charles River Laboratories
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. LifeCell
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. GBI
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Lonza
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. SGS Société Générale de Surveillance SA
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Perfectus Biomed Limited
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample